Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity.
about
Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicityA novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's diseaseDecreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulationA genome-scale RNA-interference screen identifies RRAS signaling as a pathologic feature of Huntington's diseaseMutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathwayPathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.Cellular inclusion bodies of mutant huntingtin exon 1 obscure small fibrillar aggregate species.Detection of Mutant Huntingtin Aggregation Conformers and Modulation of SDS-Soluble Fibrillar Oligomers by Small Molecules.Activation of p38MAPK contributes to expanded polyglutamine-induced cytotoxicity.Modeling Huntington disease in yeast: perspectives and future directions.Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington's Disease Induced by 3-Nitropionic AcidThe extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target (Review).CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease.Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features.Impaired TrkB-mediated ERK1/2 activation in huntington disease knock-in striatal cells involves reduced p52/p46 Shc expressionAn aggregation sensing reporter identifies leflunomide and teriflunomide as polyglutamine aggregate inhibitors.BimEL as a possible molecular link between proteasome dysfunction and cell death induced by mutant huntingtinHuntington's disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads databaseHsp70 and Hsp40 functionally interact with soluble mutant huntingtin oligomers in a classic ATP-dependent reaction cycleERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease.Targets for future clinical trials in Huntington's disease: what's in the pipeline?Forkhead transcription factor FOXO3a levels are increased in Huntington disease because of overactivated positive autofeedback loop.Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspectiveMicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.Systematic interaction network filtering identifies CRMP1 as a novel suppressor of huntingtin misfolding and neurotoxicityHuntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdhQ111 Model of HD.Inhibitors of metabolism rescue cell death in Huntington's disease models.Human pluripotent stem cells: applications and challenges in neurological diseases.Genes and environment: novel, functional polymorphism in the human cathepsin L (CTSL1) promoter disrupts a xenobiotic response element (XRE) to alter transcription and blood pressure.Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's DiseaseKorean Red Ginseng Extract Attenuates 3-Nitropropionic Acid-Induced Huntington's-Like SymptomsImpaired TrkB Signaling Underlies Reduced BDNF-Mediated Trophic Support of Striatal Neurons in the R6/2 Mouse Model of Huntington's Disease.Transcriptional signatures in Huntington's disease.A novel target for Huntington's disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathologyMAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibitionNetwork analysis of human post-mortem microarrays reveals novel genes, microRNAs, and mechanistic scenarios of potential importance in fighting huntington's disease.Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.Polyphenolic compounds for treating neurodegenerative disorders involving protein misfolding.The Role of Striatal-Enriched Protein Tyrosine Phosphatase (STEP) in Cognition.
P2860
Q28239309-C49A1143-16C3-4960-A64C-FD9BB0177D4EQ28389607-88FEEA39-620A-4402-9FD0-0E0F9EC49212Q28479035-406176CD-1EB8-48DF-9883-F25F30FA0B11Q28485362-E97042ED-22DF-4B1C-ACE8-69AAF436222EQ28576523-F51BF8BE-C4B4-46EF-9C47-9A998CAD7CF0Q30490028-8EF876CA-F49D-4DD9-8B7E-140226797D91Q30528735-BF11226D-0815-431C-9A19-BD06BEDBFD94Q30547549-888F8626-39EE-42A9-A662-D5DDD314C30BQ33332140-B15302CA-0D3C-4ECC-9974-2BAAF95F7C8DQ33575494-AE218218-4092-4CB7-AACF-7B41ABBD28A8Q33636220-41DD234F-5DD3-4AC6-8AFB-3DDDC8BA18C9Q33674924-7005CEEF-DA77-492F-8CEC-00EB3741768EQ33773689-CA47F555-7FD0-4B0E-9541-AA30A2DE4822Q33931283-BF3E3070-2FCC-47B8-9892-83B4F94B9C59Q33967163-640D1281-4096-4704-B56B-9C12AC3A861CQ34066654-2C854977-C779-44A1-B432-934B9B1F90B2Q34097076-26CAB69F-7DB8-4CED-8825-F27A57379E74Q34319766-A235205D-ABCC-4F9C-8F03-EDF958546A36Q34352145-B9A2AA88-0522-4274-B568-9A3522D0738EQ34424253-65C8D81A-8A0D-45AA-A68A-B2C5D6B7A4AFQ34435001-02796F65-13C5-4424-96F0-33AC48889850Q34552736-6B20AAC0-71A1-4CC7-A4FA-FA4DF88E42F8Q35024695-CB812308-0798-4407-949E-FEE76E98963EQ35105770-604283ED-A759-4A51-986E-BE5A73F36E73Q35552239-86B75492-0F2E-4CEA-8659-8545512D3620Q35561965-CF09ED44-83F3-48C0-93CB-B9B23212650CQ35867566-B247DF1D-4515-4330-AA9D-F8FDC2C366A8Q35971716-2F4A0A46-5FFA-42E7-898E-27F26A42DAA5Q36193696-285C1910-2667-498B-8DEA-75BDED9F23A8Q36338800-E51B1C3F-7138-40E5-AA42-3B0D17F4C448Q36588268-AA90F311-2245-412E-A33A-37A7164856B3Q36599891-7AA82E9C-317D-4CCA-A9D7-6BA6E0623B54Q36665616-4B00EFF6-07E2-472E-805E-277994E0D947Q36752799-DD3368D9-6485-4E98-A4F4-B37539C49AA4Q37012760-D7236EA6-610C-4628-94D4-D7AA4F4DF8C9Q37012789-006B596E-424F-4717-A594-D2B58B934016Q37453183-1C196BEC-F378-4D38-B7D0-A058CB7598C9Q37603401-97D4AB49-5F50-44A5-A52F-A6F3BDA12C1BQ37775038-E609E511-B2D2-472C-B35D-AA777B90840BQ37921617-D2D57F78-D729-4BE9-8070-375C5628E191
P2860
Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Mutant huntingtin alters MAPK ...... untingtin-associated toxicity.
@ast
Mutant huntingtin alters MAPK ...... untingtin-associated toxicity.
@en
Mutant huntingtin alters MAPK ...... untingtin-associated toxicity.
@nl
type
label
Mutant huntingtin alters MAPK ...... untingtin-associated toxicity.
@ast
Mutant huntingtin alters MAPK ...... untingtin-associated toxicity.
@en
Mutant huntingtin alters MAPK ...... untingtin-associated toxicity.
@nl
prefLabel
Mutant huntingtin alters MAPK ...... untingtin-associated toxicity.
@ast
Mutant huntingtin alters MAPK ...... untingtin-associated toxicity.
@en
Mutant huntingtin alters MAPK ...... untingtin-associated toxicity.
@nl
P2093
P356
P1476
Mutant huntingtin alters MAPK ...... huntingtin-associated toxicity
@en
P2093
Aleksey Kazantsev
Andrew Strand
Barbara L Apostol
Erik S Schweitzer
J Lawrence Marsh
James M Olson
Judit Pallos
Katalin Illes
Leslie Michels Thompson
P304
P356
10.1093/HMG/DDI443
P50
P577
2005-12-05T00:00:00Z